Colin E. Wark is a seasoned professional specializing in data protection and privacy management, currently serving as the Senior Data Protection and Privacy Manager at the Coalition for Epidemic Preparedness Innovations (CEPI) since November 2022. In this role, Colin leads initiatives to ensure global GDPR compliance and integrates data privacy into business processes. Prior to CEPI, Colin held the position of Head of Data Protection, Data & Software Applications at Lodders Solicitors LLP from May 2018 to November 2022, focusing on data governance and compliance as the firm's Data Protection Officer. Colin's earlier experience includes roles as an International & Environmental Compliance Advisor at Valpak Limited and a Data Analyst at Drever & Heddle, as well as legal training as a Trainee Solicitor. Colin holds a Diploma in Professional Legal Practice and a Bachelor of Laws (LLB) from the University of Glasgow.
This person is not in any teams
This person is not in any offices
CEPI (Coalition for Epidemic Preparedness Innovations)
2 followers
CEPI is an innovative partnership between public, private, philanthropic, and civil organisations, launched at Davos in 2017, to develop vaccines against future epidemics. Prior to COVID-19, CEPI’s work focused on developing vaccines against the Ebola Virus Disease, Lassa virus, Middle East Respiratory Syndrome coronavirus, Nipah virus, Rift Valley Fever virus and Chikungunya virus. It has over 20 vaccine candidates against these pathogens in development. CEPI has also invested in new platform technologies for rapid vaccine development against unknown pathogens (Disease X). During the COVID-19 pandemic, CEPI initiated multiple programmes to develop vaccines against SARS-CoV-2 and its variants with a focus on speed, scale, and access. These programmes leverage the rapid response platforms developed by CEPI’s partners prior to the emergence of COVID-19, as well as new collaborations. The aim is to advance clinical development of a diverse portfolio of safe and effective COVID-19 candidates and to enable fair allocation of these vaccines worldwide through COVAX. CEPI’s 5-year plan lays out a $3.5 billion roadmap to compress vaccine development timelines to 100 days, develop a broadly protective vaccine against COVID-19 and other Betacoronaviruses, and create a “library” of vaccine candidates for use against known and unknown pathogens. The plan is available at www.endpandemics.cepi.net